263. Cerebrotendinous xanthomatosis Clinical trials / Disease details
Clinical trials : 5 / Drugs : 10 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 4
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01613898 (ClinicalTrials.gov) | August 2010 | 22/5/2012 | Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis | Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis | Cerebrotendinous Xanthomatosis (CTX) | Biological: Blood tests | Sheba Medical Center | NULL | Recruiting | 10 Years | N/A | Both | 17 | N/A | Israel |